Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
01 1Synnat Pharma
02 1Seqens
03 2CF Pharma
04 1Transo-Pharm USA LLC
05 1LGM Pharma
06 1Wavelength Pharmaceuticals
07 1Shanghai Minbiotech
08 1Farmhispania
09 1TAPI Technology & API Services
10 1ALP Pharm
11 1Alkaloids Corporation
12 1Anhui BBCA Likang pharmaceutical
13 1Beijing Fukangren Biopharmaceutical
14 3GLAND PHARMA LIMITED
15 1Jiangsu Hengrui Medicine
16 1Jin Dun Medical
17 1Synthland
18 1Tecoland Corporation
19 1Teva Pharmaceutical Industries
20 1Yonsung Fine Chemicals
21 1Zhuhai Rundu Pharmaceutical
01 8China
02 1France
03 2Hungary
04 5India
05 3Israel
06 1South Korea
07 1Spain
08 3U.S.A
01 10Active
02 1Inactive
03 13Blank
01 5Valid
02 19Blank
01 24Blank
01 1WC-0427
02 23Blank
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-06-23
Pay. Date : 2017-05-09
DMF Number : 23554
Submission : 2010-02-21
Status : Active
Type : II
Certificate Number : CEP 2016-200 - Rev 01
Issue Date : 2024-10-23
Type : Chemical
Substance Number : 2763
Status : Valid
NDC Package Code : 58175-0541
Start Marketing Date : 2010-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : Canada DMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24902
Submission : 2012-08-27
Status : Active
Type : II
Certificate Number : CEP 2021-064 - Rev 02
Issue Date : 2024-02-23
Type : Chemical
Substance Number : 2763
Status : Valid
Available Reg Filing : ASMF |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-03-19
Pay. Date : 2024-01-22
DMF Number : 39123
Submission : 2024-01-29
Status : Active
Type : II
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-04-14
Pay. Date : 2020-04-09
DMF Number : 24999
Submission : 2011-05-30
Status : Active
Type : II
Certificate Number : R1-CEP 2016-285 - Rev 00
Issue Date : 2022-09-26
Type : Chemical
Substance Number : 2763
Status : Valid
NDC Package Code : 17404-1024
Start Marketing Date : 2012-09-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : CN, RU |
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-23
Pay. Date : 2012-11-13
DMF Number : 23130
Submission : 2009-09-28
Status : Active
Type : II
Certificate Number : R1-CEP 2016-093 - Rev 00
Issue Date : 2022-05-16
Type : Chemical
Substance Number : 2763
Status : Valid
Available Reg Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-09-09
Pay. Date : 2014-01-22
DMF Number : 24969
Submission : 2012-08-27
Status : Active
Type : II
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22962
Submission : 2009-07-21
Status : Active
Type : II
Date of Issue : 2019-03-05
Valid Till : 2022-03-04
Written Confirmation Number : WC-0427
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29738
Submission : 2015-09-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-07-15
Pay. Date : 2020-06-09
DMF Number : 34425
Submission : 2019-12-26
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-07-27
Pay. Date : 2015-07-17
DMF Number : 25511
Submission : 2011-11-17
Status : Active
Type : II
NDC Package Code : 57884-0018
Start Marketing Date : 2011-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (2kg/2kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24033
Submission : 2010-07-14
Status : Inactive
Type : II
NDC Package Code : 40016-007
Start Marketing Date : 2010-05-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R0-CEP 2021-236 - Rev 00
Issue Date : 2022-09-15
Type : Chemical
Substance Number : 2763
Status : Valid
A Cisatracurium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cisatracurium, including repackagers and relabelers. The FDA regulates Cisatracurium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cisatracurium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cisatracurium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cisatracurium supplier is an individual or a company that provides Cisatracurium active pharmaceutical ingredient (API) or Cisatracurium finished formulations upon request. The Cisatracurium suppliers may include Cisatracurium API manufacturers, exporters, distributors and traders.
click here to find a list of Cisatracurium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 21 companies offering Cisatracurium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?